- Report
- May 2026
- 500 Pages
Global
From €3629EUR$3,995USD£3,132GBP
- Report
- April 2026
- 1300 Pages
Global
From €4538EUR$4,995USD£3,916GBP
- Report
- March 2026
- 1500 Pages +
Global
From €4538EUR$4,995USD£3,916GBP
- Report
- May 2026
- 700 Pages
Global
From €4538EUR$4,995USD£3,916GBP
- Report
- January 2026
- 489 Pages
Global
From €4497EUR$4,950USD£3,881GBP
- Report
- November 2025
- 367 Pages
Global
From €4497EUR$4,950USD£3,881GBP
- Report
- September 2025
- 564 Pages
Global
From €4497EUR$4,950USD£3,881GBP
- Report
- November 2025
- 150 Pages
Global
From €5405EUR$5,950USD£4,665GBP
- Report
- June 2026
- 189 Pages
Global
From €3220EUR$3,545USD£2,779GBP
€3578EUR$3,939USD£3,088GBP
- Report
- June 2026
- 182 Pages
Global
From €3220EUR$3,545USD£2,779GBP
€3578EUR$3,939USD£3,088GBP
- Report
- June 2026
- 184 Pages
Global
From €3220EUR$3,545USD£2,779GBP
€3578EUR$3,939USD£3,088GBP
- Report
- January 2026
- 184 Pages
Global
From €3220EUR$3,545USD£2,779GBP
€3578EUR$3,939USD£3,088GBP
- Report
- January 2026
- 187 Pages
Global
From €3220EUR$3,545USD£2,779GBP
€3578EUR$3,939USD£3,088GBP
- Report
- January 2026
- 197 Pages
Global
From €3220EUR$3,545USD£2,779GBP
€3578EUR$3,939USD£3,088GBP
- Report
- November 2025
- 198 Pages
Global
From €3220EUR$3,545USD£2,779GBP
€3578EUR$3,939USD£3,088GBP
- Report
- April 2026
- 148 Pages
Global
From €3633EUR$3,999USD£3,135GBP
- Report
- January 2026
- 164 Pages
Global
From €4451EUR$4,900USD£3,842GBP
- Report
- February 2026
Global
From €4451EUR$4,900USD£3,842GBP
- Report
- February 2026
- 250 Pages
Global
From €4079EUR$4,490USD£3,520GBP
- Report
- April 2026
- 150 Pages
Global
From €5405EUR$5,950USD£4,665GBP

The Cancer Research market is a subset of the Drug Discovery market, focused on the development of treatments for cancer. This market is composed of a variety of stakeholders, including pharmaceutical companies, research institutions, and government agencies. These stakeholders collaborate to develop new treatments and therapies for cancer, as well as to improve existing treatments. The market is driven by the need to find new and effective treatments for cancer, as well as to improve the quality of life for those affected by the disease.
The Cancer Research market is highly competitive, with many companies vying for a share of the market. Companies in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. These companies are engaged in research and development of new treatments and therapies for cancer, as well as the marketing and distribution of existing treatments. Show Less Read more